Kezia Gaitskell

ORCID: 0000-0002-2474-1159 · 10 papers in corpus
observational 2025
Biomedicines ·doi:10.3390/biomedicines13102381

Background/Objectives: To evaluate the clinicopathological features, treatment, and survival outcomes and to identify independent prognosticators for recurrence and mortality in patients with endometrioid ovarian cancer. Methods: The medica…

other 2024
Nature genetics ·doi:10.1038/s41588-024-01873-w

The complex and dynamic cellular composition of the human endometrium remains poorly understood. Previous endometrial single-cell atlases profiled few donors and lacked consensus in defining cell types. We introduce the Human Endometrial Ce…

other 2024
Translational cancer research ·doi:10.21037/tcr-24-83

BACKGROUND: Ovarian clear cell carcinoma (OCCC) is a rare and distinct subtype of epithelial ovarian cancer (EOC). It is unique in several biological aspects. This study analyzes the clinicopathological features and survival outcome of pati…

meta-analysis 2023
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd007930.pub3

BACKGROUND: Many women, and other females, with epithelial ovarian cancer (EOC) develop resistance to conventional chemotherapy drugs. Drugs that inhibit angiogenesis (development of new blood vessels), essential for tumour growth, control …

2023
·doi:10.1101/2023.11.03.564728

Abstract The human endometrium, the inner lining of the uterus, exhibits complex, dynamic changes throughout the menstrual cycle in response to ovarian hormones. Aberrant response of endometrial cells to hormones is associated with multiple…

observational 2022
Cancer epidemiology ·doi:10.1016/j.canep.2021.102074

BACKGROUND: Ovarian cancer is the fifth leading cause of cancer mortality in UK women. Ovarian cancer survival varies by disease stage at diagnosis, but evidence is mixed on the effect of tumour histological type (histotype) and other facto…

observational 2018
International journal of cancer ·doi:10.1002/ijc.31063

Ovarian cancer risk is known to be reduced amongst women who have had children, but reported associations with breastfeeding are varied. Few studies have had sufficient power to explore reliably these associations by tumour histotype. In a …

observational 2016
·doi:10.5287/ora-devd8y54d

There is growing evidence that the different histological types of ovarian cancer have diverse origins. Many high-grade serous tumours (the most common type) are hypothesised to arise from the fallopian tubes, while endometrioid and clear c…

observational 2016
British journal of cancer ·doi:10.1038/bjc.2016.80

BACKGROUND: Tubal ligation is known to be associated with a reduction in ovarian cancer risk. Associations with breast, endometrial and cervical cancers have been suggested. We investigated associations for 26 site-specific cancers in a lar…

observational 2016
International journal of cancer ·doi:10.1002/ijc.29856

Histopathological and molecular studies suggest that different histological subtypes (histotypes) of ovarian cancer have different aetiologies. Few studies have been large enough to explore reliably the effect of tubal ligation (sterilizati…